Investor Relations Contacts

Key Facts

Latest Aide Memoire

AstraZeneca at a glance



Upcoming events

Full-year and Q4 2019 Results

Full-Year 2019 Investor Roadshows – Amsterdam, Brussels, Edinburgh, Frankfurt, London, Milan, Paris, Stockholm, Zurich, Boston, Chicago, Denver, Los Angeles, Montreal, New York, San Francisco and Toronto

SVB Leerink conference (NYC, NY)

Second interim dividend ex-dividend date

Second interim dividend record date


Annual Reports

 

2006-2014



Investor enquiries

Main Contacts

Thomas Kudsk Larsen

Henry Wheeler

Oncology

Josie Afolabi

BioPharmaceuticals (Respiratory)

Craig Marks

Finance, fixed income

Christer Gruvris

正规365体育投注BioPharmaceuticals (CV, Metabolism)

Tom Waldron

正规365体育投注Other medicines

Jennifer Kretzmann

Corporate access, retail investors

Nick Stone

正规365体育投注BioPharmaceuticals (Renal), ESG

US general enquiries


  • Shareholder information

    正规365体育投注Please find relevant shareholder information and shareholder tools on this page


  • Shareholder FAQs

    正规365体育投注Answers to frequently asked shareholder questions


  • Governance

    We apply the principles of good corporate governance in the UK Corporate Governance Code and related guidance